232 related articles for article (PubMed ID: 24492617)
1. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation.
Ma J; Tang X; Wong P; Jacobs B; Borden EC; Bedogni B
J Biol Chem; 2014 Mar; 289(12):8442-9. PubMed ID: 24492617
[TBL] [Abstract][Full Text] [Related]
2. Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.
Qiu H; Tang X; Ma J; Shaverdashvili K; Zhang K; Bedogni B
Mol Cell Biol; 2015 Nov; 35(21):3622-32. PubMed ID: 26283728
[TBL] [Abstract][Full Text] [Related]
3. MT1-MMP and ADAM10/17 exhibit a remarkable overlap of shedding properties.
Werny L; Grogro A; Bickenbach K; Bülck C; Armbrust F; Koudelka T; Pathak K; Scharfenberg F; Sammel M; Sheikhouny F; Tholey A; Linder S; Becker-Pauly C
FEBS J; 2023 Jan; 290(1):93-111. PubMed ID: 35944080
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17.
Alabi RO; Lora J; Celen AB; Maretzky T; Blobel CP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673337
[TBL] [Abstract][Full Text] [Related]
5. Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.
van Tetering G; van Diest P; Verlaan I; van der Wall E; Kopan R; Vooijs M
J Biol Chem; 2009 Nov; 284(45):31018-27. PubMed ID: 19726682
[TBL] [Abstract][Full Text] [Related]
6. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
Bozkulak EC; Weinmaster G
Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
[TBL] [Abstract][Full Text] [Related]
7. When MT1-MMP meets ADAMs.
Wong HL; Cao R; Jin G; Chan KM; Cao Y; Zhou Z
Cell Cycle; 2012 Aug; 11(15):2793-8. PubMed ID: 22801544
[TBL] [Abstract][Full Text] [Related]
8. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
[TBL] [Abstract][Full Text] [Related]
9. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
11. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.
Anderegg U; Eichenberg T; Parthaune T; Haiduk C; Saalbach A; Milkova L; Ludwig A; Grosche J; Averbeck M; Gebhardt C; Voelcker V; Sleeman JP; Simon JC
J Invest Dermatol; 2009 Jun; 129(6):1471-82. PubMed ID: 18971959
[TBL] [Abstract][Full Text] [Related]
12. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
[TBL] [Abstract][Full Text] [Related]
13. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
Li Z; Takino T; Endo Y; Sato H
Cancer Sci; 2017 Mar; 108(3):347-353. PubMed ID: 27987367
[TBL] [Abstract][Full Text] [Related]
14. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
15. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.
Paumier JM; Py NA; García-González L; Bernard A; Stephan D; Louis L; Checler F; Khrestchatisky M; Baranger K; Rivera S
FASEB J; 2019 Feb; 33(2):2910-2927. PubMed ID: 30332299
[TBL] [Abstract][Full Text] [Related]
16. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
17. Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL.
Sulis ML; Saftig P; Ferrando AA
Leukemia; 2011 Oct; 25(10):1564-9. PubMed ID: 21625236
[TBL] [Abstract][Full Text] [Related]
18. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
[TBL] [Abstract][Full Text] [Related]
19. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.
Nakamura H; Suenaga N; Taniwaki K; Matsuki H; Yonezawa K; Fujii M; Okada Y; Seiki M
Cancer Res; 2004 Feb; 64(3):876-82. PubMed ID: 14871815
[TBL] [Abstract][Full Text] [Related]
20. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
